About the Company
We do not have any company description for PAVmed Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on PAVmed Inc.
PAVmed Reports Q2 2025 Financial Results and Developments
In its second quarter of 2025, PAVmed Inc. reported significant business developments and financial results. Lucid Diagnostics processed 2,756 EsoGuard tests, generating $1.2 million in revenue, and ...
PAVmed Inc. (NASDAQ:PAVM) Q1 2025 Earnings Call Transcript
PAVmed Inc. beats earnings expectations. Reported EPS is $337.07, expectations were $-0.29. Operator: Good morning, and welcome to the PAVmed’s First Quarter 2025 Business Update Conference Call ...
Lucid Diagnostics Reports Q2 2025 Financial Results
Pavmed ( ($PAVM) ) has released its Q2 earnings. Here is a breakdown of the information Pavmed presented to its investors. Lucid Diagnostics Inc., ...
PAVmed Inc. (PAVM) Q3 2024 Earnings Call Transcript
PAVmed Inc. (NASDAQ:PAVM) Q3 2024 Earnings Call Transcript November 14, 2024 8:30 AM ETCompany ParticipantsMatt Riley - Director of IRLishan Aklog - ...
PAVmed to Hold a Business Update Conference Call on May 12, 2022
PAVmed to Hold a Business Update Conference Call on May 12, 2022 Company conference call and webcast at 4:30 PM EDT April 26, 2022 08:25 AM Eastern Daylight Time ...
PAVmed to Hold a Business Update Conference Call on August 16, 2022
PAVmed Inc. announced that the Company will host a business update conference call on Tuesday, August 16, 2022, at 4:30 PM EDT.
PAVmed Inc. (PAVM) Q4 2023 Earnings Call Transcript
PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Conference Call March 27, 2024 8:30 AM ETCompany ParticipantsDennis McGrath - Executive Vice President & ...
PAVmed to Hold Business Update Conference Call on February 22, 2021
NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company ...
PAVmed Adds EsoCure™ Esophageal Ablation Device with ... - Nasdaq
PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and ...
Why PAVmed Inc. (PAVM) Dipped More Than Broader Market Today
In the latest market close, PAVmed Inc. (PAVM) reached $2.07, with a -1.43% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.95%. Meanwhile ...
PAVmed Inc. (NASDAQ:PAVM) Q3 2024 Earnings Call Transcript
PAVmed Inc. (NASDAQ: PAVM) Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good morning, and welcome to the PAVmed’s Third Quarter 2024 Business Update Conference Call.
PAVmed to Hold a Business Update Conference Call and Webcast on August ...
PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today ...
Similar Companies
Loading the latest forecasts...